The average P/S ratio for VERA's competitors is 221.14, providing a benchmark for relative valuation. Vera Therapeutics Inc Corp (VERA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.